2[2]Strasberg S M, Dehdashti F, Siegel B A, et al.Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma:a prospective database study[J]. Ann Surg, 2001,233(3) :293.
4Moshe Bocher,Adi Balan,Yodphat Krausz,Yigal Shrem,Albert Lonn,Michael Wilk,Roland Chisin. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images[J] 2000,European Journal of Nuclear Medicine(6):619～627
5P. Rigo,P. Paulus,B. J. Kaschten,R. Hustinx,T. Bury,G. Jerusalem,T. Benoit,J. Foidart-Willems. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose[J] 1996,European Journal of Nuclear Medicine(12):1641～1674
6Lowe VJ,DeLong DM,Hoffman JM,et al.Optimum scanning protocol for FDG PET evaluation of pulmonary malignancy[].The Journal of Nuclear Medicine.1995
7Yasuda S,Takahashi W,Takagi S,et al.Factor influencing physiological FDG uptake in the intestine[].Tokai Journal of Experimental and Clinical Medicine.1998
8Delbeke D.Oncological applications of FDG PET imaging: brain tumors,colorectal cancer lymphoma and melanoma[].The Journal of Nuclear Medicine.1999
9Meikle SR,Bailey DL,Hooper PK,et al.Simultaneous emission and transmission measurements for attenuation correction in whole-body PET[].The Journal of Nuclear Medicine.1995
10Beets G,Penninckx F,Schiepers C,et al.Clinical value of whole-body position emission tomography with 18 F-FDG in recurrent colorectal cancer[].British Journal of Surgery.1994
